STANDARD BIOTOOLS
LIVE

Serial Number

97977637

Owner

STANDARD BIOTOOLS INC.

Attorney

R. Gwen Peterson

Filing Date

Apr 13, 2022

Add to watchlist:

No watchlists yet
View on USPTO

STANDARD BIOTOOLS Trademark

Serial Number: 97977637

STANDARD BIOTOOLS is a trademark filed by STANDARD BIOTOOLS INC. on April 13, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 40 (Treatment & Processing). The application is currently pending registration.

Owner Contact Info

STANDARD BIOTOOLS INC. (7 trademarks)

2 TOWER PLACE, SUITE 2000
SOUTH SAN FRANCISCO, CA 94080

Entity Type: 03

Trademark Details

Filing Date

April 13, 2022

Registration Date

Not Registered

Published for Opposition

December 3, 2024

Goods & Services

Custom fabrication of antibody conjugate reagents; custom fabrication of microfluidic flow controls and biochips employing microfluidic technology

Laboratory equipment, namely, cytometers used to measure chemical and physical characteristics of cells and biomolecules and downloadable software for the operation of and analysis of the data from same; microfluidic instrumentation for use in analytical chemistry and other scientific fields where molecular or cell separation is desirable or movement of gases or liquids on a microscale is needed, and downloadable software for the operation of and analysis of the data from same and downloadable software for biochip design embodying same; mass spectrometric instrumentation, namely, flow cytometers used to measure chemical and physical characteristics of cells and other particles by means of biospectrometry and optical detection and downloadable software for the operation of and analysis of the data from same and downloadable software for assay and workflow design for same; laboratory instruments and devices used for genetic research, namely, microfluidic flow controls; laboratory microfluidic instruments and devices, namely, microfluidic flow controls for use in genetic research where molecular or cell separation is desirable or movement of gases or liquids on a microscale is needed; laboratory instruments, namely, mass spectrometric instrumentation for genetic research, namely, flow cytometers by means of biospectrometry and optical detection where it is desirable to measure chemical and physical characteristics of cells and other particles

Nucleic medical diagnostic reagents and assays for testing of body fluids; nucleic acid sequences and chemical reagents for medical and veterinary purposes

Assays and reagents for use in genetic research and research in the field of cell detection, cell characterization, biochemical and chemical analysis, biological function testing, genotyping, and biomolecule sequencing; biochemical reagents commonly known as probes for non-medical purposes for detecting and analyzing molecules in protein or nucleotide arrays; electrodiagnostic preparations for scientific or research use; reagents for chemical analyses other than for medical or veterinary purposes; reagents for scientific or medical research use; reagents for use in scientific apparatus for chemical or biological analysis; diagnostic reagents other than for medical or veterinary purposes; diagnostic reagents for in vitro use in biochemistry, clinical chemistry, microbiology, and genotyping, other than for medical or veterinary purposes.

Instruments and devices for use in medical diagnostic research, namely, microfluidic flow controls; microfluidic instruments and devices, namely, microfluidic flow controls for use in medical diagnostic research and for other medical uses where molecular or cell separation is desirable or movement of gases or liquids on a microscale is needed; biochips for medical purposes which employ microfluidic pumps and valves; mass spectrometric instrumentation for medical purposes for use in medical diagnostic research and for medical uses, namely, flow cytometers by means of mass-spectrometry and optical detection where it is desirable to measure chemical and physical characteristics of cells and other particles

Filing History

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Jun 2, 2025 ETOP
OPPOSITION INSTITUTED NO. 999999
Jun 2, 2025 OP.I
EXTENSION OF TIME TO OPPOSE RECEIVED
Dec 23, 2024 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 3, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 3, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 27, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 9, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 18, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 18, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 18, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 18, 2024 CNEA
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Aug 12, 2024 GNS1
SUBSEQUENT FINAL EMAILED
Aug 12, 2024 GNSF
SUBSEQUENT FINAL REFUSAL WRITTEN
Aug 12, 2024 CFRC
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 18, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 18, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 18, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 4, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jun 4, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jun 4, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 17, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 17, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 17, 2024 ERFR
DIVISIONAL PROCESSING COMPLETE
Mar 7, 2024 DPCC
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Feb 8, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Feb 8, 2024 XELR
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 5, 2024 AITU
DIVISIONAL REQUEST RECEIVED
Dec 13, 2023 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Dec 13, 2023 ERTD
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 24, 2023 GNFN
FINAL REFUSAL E-MAILED
Nov 24, 2023 GNFR
FINAL REFUSAL WRITTEN
Nov 24, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 14, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 13, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 13, 2023 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jul 12, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jul 12, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 13, 2023 GNRN
NON-FINAL ACTION E-MAILED
Apr 13, 2023 GNRT
NON-FINAL ACTION WRITTEN
Apr 13, 2023 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 15, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 14, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 14, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 14, 2022 GNRN
NON-FINAL ACTION E-MAILED
Dec 14, 2022 GNRT
NON-FINAL ACTION WRITTEN
Dec 14, 2022 CNRT
ASSIGNED TO EXAMINER
Dec 12, 2022 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Nov 15, 2022 AMPX
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 15, 2022 CHAN
ASSIGNED TO LIE
Nov 15, 2022 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Sep 28, 2022 PARI
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 26, 2022 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Sep 26, 2022 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 26, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 26, 2022 REAP
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 19, 2022 NWOS
NEW APPLICATION ENTERED
Apr 16, 2022 NWAP